Product News
New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals

New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals

ORLANDO, Fla. – September 16, 2014 – Vestagen Technical Textiles, Inc. today announced a new standard in the patient experience at hospitals. The myComfort™ line of patient apparel is protected by Vestex®, Vestagen’s active barrier fabric that is fluid repellant, breathable and in studies done in a hospital environment, shown to inhibit the growth of bacteria on the fabrici.
i G. Bearman, et al., A crossover trial of antimicrobial scrubs to reduce methicillin-resistant Staphylococcus aureus burden on healthcare worker apparel. Infection Control and Hospital Epidemiology. 2012: Vol. 33; No. 3.

“It’s time to address the role clothing plays in the chain of transmission. We want myComfort to be a visible sign to patients that their hospital is committed to safety and dignity. That’s the kind of protection and confidence patients deserve,” said Uncas “Ben” B. Favret III, president and CEO of Vestagen.

The myComfort garments are launching on the heels of Vestagen’s introduction of a line of protective garments for healthcare workers this summer. The line of scrubs and physician coats are sold under the brand myGuardian™. Available at, both product lines were developed with Vestagen’s proprietary Vestex fabric, offering the only combination of breathability, fluid repellency and antimicrobial properties in the industry.

In July, Baptist Health of Jacksonville, Fla. was the first large hospital system to adopt myGuardian garments system-wide and will be the first to utilize myComfort for patients. Baptist converted more than 6,000 team members to myGuardian uniforms and will make myComfort attire available to patients beginning this fall. Baptist leadership views its investment in Vestex protected apparel for patients and healthcare workers as a commitment to its culture of safety.

“Every healthcare organization encounters harmful, infection causing pathogens on a daily basis and it’s a tough battle. There is no magic bullet that will eliminate all contaminants healthcare workers or patients come across, but it’s important to incorporate new technology like Vestex into infection prevention arsenals to help give us the upper hand in that fight,” said Diane Raines, DNP, RN, NEA-BC, senior vice president and chief nursing officer at Baptist Health.

Decades of studies published across the world have indicated that soft surfaces in healthcare settings, including clothing, can be a highly mobile repository for the spread of pathogens that cause illness and infection. It is because of this rich body of evidence that Vestagen launched an awareness campaign called “Keep the Coat.” Additional information and resources can be found online at

About Vestagen and VESTEX®
Vestagen Technical Textiles develops and markets advanced performance textile products and technologies. Its VESTEX® active barrier technology is the first to combine fluid repellent, antimicrobial and breathability properties in one fabric for everyday protection from unanticipated fluid exposure and pathogen transmission. VESTEX is proven in a clinical setting to prevent or reduce the acquisition and retention of contaminants on clothing, reducing methicillin-resistant Staphylococcus aureus (MRSA) on the fabric by 99.99% compared to traditional uniforms. VESTEX is also comfortable, durable and affordable. Product lines, including lab coats, uniforms and patient apparel, are manufactured and sold directly by Vestagen, its retail partners and select distributors. VESTEX fabric is also available for use in garment production by approved licensees. For more information about Vestagen and VESTEX, visit

Rachel De Jesus

BLL Partners
Barbara Lindheim

Posted on September 16, 2014 in Product News, Vestagen, Vestex

Share the Story

Back to Top